Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Infertility requires quick, thorough, and cost-effective evaluation, including medical history, physical exams, and psychological support.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride doesn't affect ovulation in normal women.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.